Variation in NGFB Is Associated With Primary Affective Disorders in Women

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (Impact Factor: 3.42). 06/2011; 156B(4):401-12. DOI: 10.1002/ajmg.b.31175
Source: PubMed


Affective disorders (AFDs) are highly comorbid with substance dependence (SD) and both are genetically influenced. However, the specific etiology of the comorbidity is not well understood. We genotyped an array of 1,350 single nucleotide polymorphisms (SNPs) in or near 130 genes in 868 European-Americans (EAs), including 182 individuals with primary AFDs (PAFDs), 214 with SD comorbid with AFD (CAFD), and 472 screened controls. NGFB, which encodes nerve growth factor β and was represented in the array by 15 SNPs, showed the strongest evidence of association, but only among women with PAFDs. Six of the SNPs showed nominally significant association with PAFDs in women (P's = 0.0007-0.01); three (rs2856813, rs4332358, and rs10776799) were empirically significant based on 1,000,000 permutations (P's = 0.008-0.015). Seven haplotypes were significantly associated with PAFDs in women (P's = 0.0014-0.01), of which six were significant based on empirical permutation analysis (minimal P = 0.0045). Four diplotypes were significantly associated with PAFDs in women (global P's = 0.001-0.01). The specific diplotype GG-TC, reconstructed from rs2856813 and rs6678788, showed the strongest evidence of association with PAFDs in women (OR = 4.07, P = 4.2E-05). No SNPs or haplotypes were associated with PAFDs in men or with CAFDs in either sex. We conclude that variation in NGFB is a risk factor for PAFDs in women, but not for CAFD.

Download full-text


Available from: Huiping Zhang
  • Source
    • "This non-synonymous SNP produces an alanine to valine substitution at amino acid position 35 and is thought to have a possible functional role on intracellular processing and secretion of NGF[118]. Allelic variation at this locus has shown associations with anxiety-related traits and affective disorders [119,120]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Considerable variation is evident in response to psychological therapies for mood and anxiety disorders. Genetic factors alongside environmental variables and gene-environment interactions are implicated in the etiology of these disorders and it is plausible that these same factors may also be important in predicting individual differences in response to psychological treatment. In this article, we review the evidence that genetic variation influences psychological treatment outcomes with a primary focus on mood and anxiety disorders. Unlike most past work, which has considered prediction of response to pharmacotherapy, this article reviews recent work in the field of therapygenetics, namely the role of genes in psychological treatment response. As this is a field in its infancy, methodological recommendations are made and opportunities for future research are identified.
    Full-text · Article · Feb 2013 · Biology of Mood and Anxiety Disorders
  • Source
    • "In psychiatric research areas, Cui et al. (2011) reported that variation in NGF is associated with primary affective disorders in women. They investigated genetic variation in the NGF in 182 patients with primary affective disorders and 472 screened controls. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abnormal neurodevelopmental processes are found in the brains of schizophrenia patients. Nerve growth factor (beta polypeptide) (NGF) is known to play a major role in neuronal growth, differentiation, and neuroprotection of the brain. To investigate whether NGF polymorphisms are associated with schizophrenia patients, eight single nucleotide polymorphisms (SNPs; rs10776800, rs11102924, rs4839435, rs12760036, rs11102919, rs11466098, rs2268793, and rs6330) of the NGF were selected and genotyped by direct sequencing in 217 schizophrenia patients and 378 control subjects. SNPAnalyzer, SNPStats, and Haploview version 4.2 were used to analyze the genetic data. Multiple logistic regression models (codominant1, codominant2, dominant, recessive, overdominant, and log-additive) were performed to calculate odds ratios (ORs), 95% confidence intervals (CIs), and P values. P values (P c ) were recalculated using Bonferroni correction to better define results. It was found that the allele frequency of rs12760036 SNP of the NGF was associated with the susceptibility to schizophrenia (P c =0.0016, OR=1.65, 95% CI=1.27–2.15). Genotype frequency of rs12760036 of the NGF was also associated with schizophrenia patients (P c =0.0024, OR= 1.90, 95% CI=1.34–2.71). In the linkage disequilibrium block between rs12760036 and rs4839435, the AG and CA haplotype frequencies between schizophrenia patients and the control group were significantly different (P=0.0002; P=0.0033, respectively). These results suggest that the rs12760036 may be a risk factor to the susceptibility of schizophrenia in Korean population.
    Preview · Article · Dec 2012 · Molecular and Cellular Toxicology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this project was to study genetic and neuroendocrine biomarkers of risk in a carefully assessed population of military personnel who recently returned from war zones. Baseline and 12-month follow-up assessment data were collected on behavioral and psychosocial measures. Major findings were that the COMT Val/Met polymorphism, interacted with combat exposure to predict diagnoses of PTSD; specifically individuals with the Met allele appeared more sensitive to higher levels of combat trauma exposure. In the sample as a whole, cortisol concentrations did not differ between participants with a current diagnosis of PTSD and those without PTSD. However, among those who had a past significant trauma, there was a significant between groups effect of current PTSD (p<.05) after controlling for significant effects of past PTSD symptoms, those with current PTSD had blunted diurnal cortisol concentrations. In addition, after controlling for covariates, there was a main effect of COMT (p<.005), such that individuals homozygous for the Met allele had higher overall cortisol concentrations, particularly morning and nighttime concentrations. There was also a significant effect of a polymorphism in FKBP5, a glucocorticoid regulating gene, such that those homozygous for the C allele had elevated evening cortisol concentrations(p<05).0
    Full-text · Article · Mar 2011
Show more